OMEROS CORP (OMER)
Pharmaceutical Preparations
Latest Price
$17.17
TTM P/E
9.92
Normalized P/E
81.76
Div Yield
--
Book Value
0.33
P/B Ratio
52.60
Institutional Ownership
52.7% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BlackRock, Inc. | 6.04M | $57.0M | 8.39% | +735.0K | 2026-06-30 |
| INGALLS & SNYDER LLC | 3.66M | $34.0M | 5.08% | +100.1K | 2026-06-30 |
| UBS Group AG | 3.15M | $29.0M | 4.37% | +807.7K | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.07M | $29.0M | 4.26% | +88.8K | 2026-06-30 |
| STATE STREET CORP | 2.32M | $22.0M | 3.22% | +400.3K | 2026-06-30 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.91M | $18.0M | 2.66% | +162.1K | 2026-06-30 |
| STIFEL FINANCIAL CORP | 1.84M | $17.0M | 2.55% | +5.3K | 2026-06-30 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 962.8K | $9.0M | 1.34% | +244.2K | 2026-06-30 |
| CITADEL ADVISORS LLC | 830.0K | $7.0M | 1.15% | +115.8K | 2026-06-30 |
| Invesco Ltd. | 751.8K | $7.0M | 1.04% | +571.1K | 2026-06-30 |